Ascidian is redefining the treatment of disease by rewriting RNA. Ascidian Therapeutics was founded to rewrite RNA by editing and replacing human exons. We were inspired by ocean creatures, called Ascidians, who are primordial ancestors of vertebrates. To grow from larvae to adults, ascidians re-engineer their transcriptome through RNA editing via trans-splicing and alternative splicing. In our Brighton/Boston labs, RNA biology meets today's cutting-edge genomics, computational biology, and deep-sequencing technologies to create a new class of medicines that address the underlying causes of disease. We welcome you to come join our vibrant team and help us lead the way into a new gene therapy era. Your Role We are seeking an experienced Clinical Biostatistician to provide both strategic statistical leadership and hands-on operational execution on our clinical development program, with primary focus on Phase 1–2 trials and demonstrated experience supporting late-stage (Phase 2/3 or registrational) programs. This role is designed for an independent, highly experienced biostatistician who can operate with minimal oversight, exercise strong scientific judgment, own execution and serve as a strategic partner to Clinical Development, Regulatory, and Program Leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees